Skip to content
Home/Companies/Pharma/OctreoPharm

OctreoPharm

Pharma·Germany·Exited 2015·Held 4yr
Entry
2011
Hold
4yr
Exit
2015

Who owns OctreoPharm?

OctreoPharm was owned by IBB Ventures through VC Fonds Technologie Berlin (1997 vintage) from 2011 to 2015, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

IBB Ventures
Investor
IBB Ventures
VC Fonds Technologie Berlin · 1997 · VC

Key facts

HQGermany
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2015

More from VC Fonds Technologie Berlin

Other portfolio companies in the same fund.

Bounti
Bounti
Active
SoftwareGermany· 2026
hellomed
Active
HealthTechGermany· 2026
Level Nine
Active
ClimateTechGermany· 2026
Nox Mobility
Nox Mobility
Active
MobilityGermany· 2026
Remi Health
Remi Health
Active
HealthTechGermany· 2026
Amara
Active
HealthTechGermany· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track OctreoPharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on OctreoPharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue